Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease

European Journal of Neurology

Volumn 19, Issue 1, 2012, Pages 121-127

  Strutt, A M ^a   Simpson, R ^b   Jankovic, J ^a   York, M K ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognition; Depression; Emotion; Motor symptoms; Parkinson's disease; Subthalamic nucleus deep brain stimulation; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; LEVODOPA; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT;

ADULT; ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COGNITION; DEPRESSION; EMOTION; FEMALE; HUMAN; MALE; MENTAL HEALTH; MOOD CHANGE; MOTOR ACTIVITY; NEUROPHYSIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION; SUICIDE;

AGED; COGNITION; DEEP BRAIN STIMULATION; DEPRESSION; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84155164942     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03447.x     Document Type: Article

References (35)

1. Østergaard K, Aa Sunde N. Evolution of Parkinson's disease during 4years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 2006; 21: 624-631.
2. Kumar R, Lozano A, Montgomery E, Lang A. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord 1998; 13(Suppl 1): 73-82.
3. Anderson K, Mullins J. Behavioral changes associated with deep brain stimulation surgery for Parkinson's disease. Curr Neurol Neurosci Rep. 2003; 3: 306-313.
4. Kleiner-Fisman G, Herzog J, Fisman D, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21(Suppl 14): S290-S304.
5. Castelli L, Perozzo P, Zibetti M, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol 2006; 55: 136-144.
6. Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999; 46: 217-223.
7. Voon V, Kubu C, Krack P, Houeto J, Tröster A. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21(Suppl 14): S305-S327.
8. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614.
9. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65: 586-595.
10. Heo J, Lee K, Paek S, et al. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease. J Neurol Sci 2008; 273: 19-24.
11. Zibetti M, Torre E, Cinquepalmi A, et al. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007; 58: 218-223.
12. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-839.
13. Volkmann J, Allert N, Voges J, Weiss P, Freund H, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology. 2001; 56: 548-551.
14. Saint-Cyr J, Trépanier L, Kumar R, Lozano A, Lang A. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain. 2000; 123(Pt 10): 2091-2108.
15. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 362: 2077-2091.
16. Soulas T, Gurruchaga J, Palfi S, Cesaro P, Nguyen J, Fénelon G. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry 2008; 79: 952-954.
17. Appleby B, Duggan P, Regenberg A, Rabins P. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years' experience. Mov Disord 2007; 22: 1722-1728.
18. York M, Dulay M, Macias A, et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 2008; 79: 789-795.
19. Singh N, Gayowski T, Wagener M, Marino I. Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C. Transplantation 1999; 67: 69-72.
20. Taylor R, Lovibond PF, Nicholas MK, Cayley C, Wilson PH. The utility of somatic items in the assessment of depression in patients with chronic pain: a comparison of the Zung self-rating depression scale and the depression anxiety stress scales in chronic pain and clinical and community samples. Clin J Pain 2005; 21: 91-100.
21. Visser M, Leentjens A, Marinus J, Stiggelbout A, van Hilten J. Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord 2006; 21: 668-672.
22. Nazem SSA, Duda JE, Brown GK, Ten Have T, Stern MB, Weintraub D. Suicidal and death ideation in Parkinson's disease. Mov Disord 2008; 15: 1573-1579.
23. Voon V, Krack P, Lang A, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008; 131: 2720-2728.
24. Menza M, Defronzo Dobkin R, Marin H, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression Neurology 2008; 72: 886-892.
25. Merello M. Deep brain stimulation of the subthalamic nucleus for the treatment of parkinson's disease. In: Tarsy D, Vitek JL, Starr PA, Okun MS ed. Deep Brain Stimulation in Neurological and Psychiatric Disorders. Totowa, NJ: Humana Press, 2008: 253-275.
26. York M, Wilde EA, Simpson R, Jankovic J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. Journal of Neurological Sciences. 2009; 287: 159-171.
27. Houeto J, Mesnage V, Mallet L, et al. Behavioral disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72: 701-707.
28. Schupbach M. Neurosurgery in Parkinson's disease: a distressed mind in a repaired body? Neurology. 2006; 66: 1811-1816.
29. Schrag A, Barone P, Brown R, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007; 22: 1077-1092.
30. Ravina B, Camicioli R, Como P, et al. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007; 69: 342-347.
31. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
32. Martínez-Martín P, Valldeoriola F, Tolosa E, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord 2002; 17: 372-377.
33. Weaver FM, Follet K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with Advanced Parkinson's disease. JAMA 2009; 301: 63-73.
34. Ferrara JM, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 81: 315-319.
35. Drapier S, Raoul S, Drapier D, et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J Neurol 2005; 252: 583-588.